KSC Equity Snapshot

011000 Weekly Equity Report

GeneOne Life Science, Inc.

Latest Close 918.0 KRW 12 Jun 2026
1W Return -15.4% latest completed week
4W Return -4.4% short-term follow-through
12W Return -11.4% quarterly tape
Trend Breadth 15.4% 8 of 52 weeks active
Volume Ratio 0.2x vs 13-week average
Company Brief

What the company does

GeneOne Life Science, Inc., a biopharmaceutical company, engages in the research, development, and contract manufacturing of nucleic acid-based biopharmaceuticals. Its small molecule pipeline comprises GLS-1027, which is in Phase I clinical trial for treatment of nephropathy and inflammatory diseases; GLS-1200 that is in Phase II clinical trial to treat Rhinosinusitis; GLS-1027 and GLS-1200, which is Phase II clinical trial for treatment of COVID-19. The company's nucleic acid vaccines include GLS-3000 mRNA under feasible study and GLS-5310 DNA under phase 2 stage for the treatment of SARS-CoV-2; GLS-5100 under pre-clinical stage for prevention of herpes zoster; …

Snapshot

What the weekly tape is saying

011000 closed the latest completed week at 918.0 KRW. The 4-week return is -4.4% and the 12-week return is -11.4%. Trend Signal is inactive, Market Dynamics is 0.69. Setup signature: Risk-first tape with a 23/100 composite read.

Trend Signal Inactive
Market Dynamics No fresh buy
Price vs Trend -35.9%
Volume 0.2x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 8 Persistence of active Trend Signal over the last year and current streak.
Momentum 30 Blend of 4-week and 12-week follow-through.
Dynamics 92 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 0 Relative leadership and short-term RS change.
Volume 10 Participation compared with the 13-week volume baseline.
Risk Control 0 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
1,432 KRW
Vs Trend Line
-35.9%
Fair Value
2,416 KRW
Vs Fair Value
-62.0%
52W High
3,000 KRW
52W Low
618.0 KRW
Drawdown
-69.4%
Range Position
12.6%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W -15.4%
4W -4.4%
12W -11.4%
26W -55.2%
52W -66.4%

Trend read

Active Streak
0 weeks
52W Active Weeks
8
52W Active Breadth
15.4%
Sector Scope
KR Healthcare
Sector Rank
61 of 63
Sector Percentile
3.2%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
0.69
4W MD Change
370.3%
Relative Strength
-75.11
4W RS Change
1.1%
Expectation
Negative
Probability
34.40%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
8.2M
13W Average
35.3M
52W Average
11.9M
Vs 13W
0.2x
Vs 52W
0.7x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
20.6%
52W Volatility
11.7%
Upside Weeks
16
Downside Weeks
36
Downside Breadth
69.2%
Avg Gain / Loss
10.1% / -6.6%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
KSC
Country
KR
Sector
Healthcare
Industry
Biotechnology
Currency
KRW
Market Cap
104.4B

Opportunity signals

  • Market Dynamics is positive on the latest completed week.

Risk signals

  • Trend Signal is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • The share remains more than 20% below its 52-week high.
  • The latest week was a sharp negative move.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 918.0 KRW -15.4% 1,432 KRW 2,416 KRW 0.69 -75.11 8.2M Off
5 Jun 2026 1,085 KRW -3.3% 1,476 KRW 2,439 KRW 0.67 -71.71 32.7M Off
29 May 2026 1,122 KRW -14.5% 1,508 KRW 2,464 KRW 0.47 -72.77 26.4M Off
22 May 2026 1,312 KRW 36.7% 1,541 KRW 2,489 KRW 0.10 -67.09 141.9M Off
15 May 2026 960.0 KRW -15.0% 1,568 KRW 2,513 KRW -0.26 -75.93 73.3M Off
8 May 2026 1,129 KRW 30.5% 1,608 KRW 2,538 KRW -0.43 -72.43 12.4M Off
1 May 2026 865.0 KRW -14.4% 1,643 KRW 2,566 KRW -0.73 -76.54 10.6M Off
24 Apr 2026 1,011 KRW -0.6% 1,689 KRW 2,600 KRW -0.94 -72.71 99.1M Off
17 Apr 2026 1,017 KRW 43.2% 1,731 KRW 2,632 KRW -1.23 -71.99 17.7M Off
10 Apr 2026 710.0 KRW -18.2% 1,777 KRW 2,666 KRW -1.55 -79.77 16.1M Off
3 Apr 2026 868.0 KRW -10.6% 1,835 KRW 2,705 KRW -1.67 -73.65 4.4M Off
27 Mar 2026 971.0 KRW -6.3% 1,888 KRW 2,741 KRW -1.59 -71.44 12.4M Off
20 Mar 2026 1,036 KRW -4.7% 1,931 KRW 2,775 KRW -1.56 -71.86 3.6M Off
13 Mar 2026 1,087 KRW 0.3% 1,971 KRW 2,811 KRW -1.52 -69.45 3.2M Off